AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.050
-0.030 (-2.78%)
At close: Jul 3, 2025, 1:00 PM
1.090
+0.039 (3.76%)
After-hours: Jul 3, 2025, 1:31 PM EDT

AN2 Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
3241609185--
Upgrade
Market Cap Growth
-57.69%-93.23%229.57%---
Upgrade
Enterprise Value
-35-5248681--
Upgrade
Last Close Price
1.051.3820.499.53--
Upgrade
PB Ratio
0.430.504.891.94--
Upgrade
P/TBV Ratio
0.430.504.891.94--
Upgrade
Debt / Equity Ratio
---0.00--
Upgrade
Quick Ratio
8.408.207.7413.3717.252.79
Upgrade
Current Ratio
8.688.437.8713.7217.702.90
Upgrade
Return on Equity (ROE)
-49.32%-49.69%-58.83%-52.08%-66.64%-359.68%
Upgrade
Return on Assets (ROA)
-29.49%-29.54%-36.07%-31.47%-38.77%-91.66%
Upgrade
Return on Capital (ROIC)
-32.48%-33.02%-39.54%-33.58%-41.71%-109.80%
Upgrade
Earnings Yield
-143.14%-124.47%-10.62%-22.15%--
Upgrade
Buyback Yield / Dilution
-14.15%-26.39%-53.85%-481.46%-2.71%-0.61%
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q